ongitudinal study across the spectrum of Alzheimer's disease associated with amyloid PET Imaging
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000014346
- Lead Sponsor
- Shonan-Atsugi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1)The past and present history of alcoholism and epilepsy 2)The past and present history of psychiatric, disorders, cerebrovascular disease, degenerative disease of the brain and head injury. 3)Severe complication including malignancy, heart failure, hepatic dysfunction, renal dysfunction, endocrine disorders, etc 4)Patients treated with antidepressants, antipsychotics,and long-term sedative-hypnotics 5)The patients that investigators need to exclude.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To investigate the deposits of beta-amyloid in brain cortex. 2)Degree of impairment of cognitive function correlate with beta-amyloid.
- Secondary Outcome Measures
Name Time Method